149 related articles for article (PubMed ID: 36931207)
1. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism.
Alomar HA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Hussein MH; Alqarni SA; Ahmad SF
J Neuroimmunol; 2023 Apr; 377():578069. PubMed ID: 36931207
[TBL] [Abstract][Full Text] [Related]
2. Methylmercury chloride exposure aggravates proinflammatory mediators and Notch-1 signaling in CD14
Ahmad SF; Bakheet SA; Ansari MA; Nadeem A; Alobaidi AF; Attia SM; Alhamed AS; Aldossari AA; Mahmoud MA
Neurotoxicology; 2021 Jan; 82():9-17. PubMed ID: 33166615
[TBL] [Abstract][Full Text] [Related]
3. CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T
Albekairi NA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Alanazi MM; Alhamed AS; Albekairi TH; Al-Mazroua HA; Ibrahim KE; Ahmad SF
Pharmacol Biochem Behav; 2022 Jun; 217():173408. PubMed ID: 35644272
[TBL] [Abstract][Full Text] [Related]
4. Cadmium exposure exacerbates immunological abnormalities in a BTBR T
Albekairi TH; Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almanaa TN; Alwetaid MY; Alqinyah M; Alnefaie HO; Ahmad SF
J Neuroimmunol; 2024 Jan; 386():578253. PubMed ID: 38064869
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Alzahrani MZ; Bakheet SA; Attia SM
Neuromolecular Med; 2018 Mar; 20(1):133-146. PubMed ID: 29468499
[TBL] [Abstract][Full Text] [Related]
6. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T
Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF
Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
[TBL] [Abstract][Full Text] [Related]
8. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM
Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736
[TBL] [Abstract][Full Text] [Related]
9. The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alasmari F; Alasmari AF; Al-Kharashi LA; Al-Qahtani QH; Attia SM
Life Sci; 2019 Nov; 237():116930. PubMed ID: 31610190
[TBL] [Abstract][Full Text] [Related]
10. DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alotaibi MR; Alasmari AF; Alshammari MA; Al-Mazroua HA; Attia SM
Eur J Pharmacol; 2019 Mar; 846():100-108. PubMed ID: 30658114
[TBL] [Abstract][Full Text] [Related]
11. Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T
Ansari MA; Attia SM; Nadeem A; Bakheet SA; Raish M; Khan TH; Al-Shabanah OA; Ahmad SF
Mol Cell Neurosci; 2017 Jul; 82():76-87. PubMed ID: 28465254
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Almutairi MM; Attia SM
J Neuroimmunol; 2017 Oct; 311():59-67. PubMed ID: 28807491
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alsanea S; Al-Hosaini KA; Mahmood HM; Alzahrani MZ; Attia SM
Neurotoxicology; 2020 Mar; 77():1-11. PubMed ID: 31811869
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
[TBL] [Abstract][Full Text] [Related]
15. Methylmercury chloride exposure exacerbates existing neurobehavioral and immune dysfunctions in the BTBR T
Al-Mazroua HA; Nadeem A; Ansari MA; Attia SM; Albekairi TH; Bakheet SA; Alobaidi AF; Alhosaini K; Alqarni SA; Ibrahim KE; Alsaad AMS; Ahmad SF
Immunol Lett; 2022 Apr; 244():19-27. PubMed ID: 35259423
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice through the inhibition of nuclear factor-kappa B signaling in B cells.
Alomar HA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Al-Mazroua HA; Alhazzani K; Assiri MA; Alqinyah M; Almudimeegh S; Ahmad SF
Brain Res Bull; 2023 Mar; 194():45-53. PubMed ID: 36646144
[TBL] [Abstract][Full Text] [Related]
17. DAPTA, a C-C Chemokine Receptor 5 (CCR5), Leads to the Downregulation of Notch/NF-κB Signaling and Proinflammatory Mediators in CD40
Alghibiwi H; Ansari MA; Nadeem A; Algonaiah MA; Attia SM; Bakheet SA; Albekairi TH; Almudimeegh S; Alhamed AS; Shahid M; Alwetaid MY; Alassmrry YA; Ahmad SF
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371605
[TBL] [Abstract][Full Text] [Related]
18. The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alshammari MA; Attia SM
Neurochem Int; 2018 Nov; 120():251-261. PubMed ID: 30227151
[TBL] [Abstract][Full Text] [Related]
19. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Khan MR; Alsaad AMS; Attia SM
Cell Signal; 2018 Dec; 52():127-136. PubMed ID: 30213685
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Attia SM; Bakheet SA; Ibrahim KE; Alqahtani F; Alqinyah M
Behav Brain Res; 2019 May; 364():213-224. PubMed ID: 30790585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
